Document Detail


Angiotensin-converting enzyme inhibitors in pediatric patients with mitral valve regurgitation-case-control study and review of the literature.
MedLine Citation:
PMID:  20576047     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To investigate the effectiveness of chronic administration of angiotensin-converting enzyme inhibitors in pediatric patients with mitral valve regurgitation.
DESIGN, SETTING, PATIENTS, INTERVENTIONS: This was a case-control study of all echocardiograms of patients with moderate-to-severe mitral valve regurgitation, who underwent chronic administration of angiotensin-converting enzyme inhibitors between January 1990 and December 2006 at a single center.
OUTCOME MEASURES: Echocardiographic parameters (left ventricular end-diastolic diameter, left ventricular posterior wall diameter, interventricular septum diameter, left atrium to aortic root diameter ratio, grade of mitral valve regurgitation, shortening fraction) were analyzed before and during therapy with angiotensin-converting enzyme inhibitors in 12 patients and compared with 12 patients without medications after one month and one year.
RESULTS: Twenty-four consecutive pediatric patients (median age of 7 years with a range 1 month-16 years) with moderate-to-severe mitral valve regurgitation were included. Data are given as standard deviation scores (z-scores) derived from body-surface-adjusted normal values. During angiotensin-converting enzyme inhibition left ventricular end-diastolic diameter decreased from mean z-score 2.04 to 1.66 (after 1 month) and to 1.73 (after 1 year), while left ventricular posterior wall diameter decreased from 0.25 to 0.12 (after 1 year), respectively. Shortening fraction, interventricular septum diameter, grade of mitral valve regurgitation, and left atrium to aortic root diameter ratio remained stable.
CONCLUSIONS: In this case-control study of patients with moderate-to-severe mitral valve regurgitation effectiveness of angiotensin-converting enzyme inhibition on left ventricular dimensions and function after 1 month and 1 year is limited. Reviewing the literature, the lack of long-term follow-up studies with large patient cohorts and controversial study-results in adults require a prospective long-term multicenter follow-up study in pediatric patients.
Authors:
Walter Knirsch; Lucie Tlach; Dominik Stambach; Urs Bauersfeld
Related Documents :
19332207 - Diastolic dysfunction and left atrial enlargement as contributing factors to functional...
7760517 - Effect of the angiotensin-converting enzyme inhibitor alacepril on ventricular function...
1935287 - Does the magnitude of mitral regurgitation determine hemodynamic response to vasodilati...
10197677 - Assessment of mitral regurgitant jets by three-dimensional color doppler.
15734407 - Acute hemodynamic benefit of left ventricular apex pacing in children.
21320507 - Three 4-letter words of hypertension-related cardiac hypertrophy: trpc, mtor, and hdac.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Congenital heart disease     Volume:  5     ISSN:  1747-0803     ISO Abbreviation:  Congenit Heart Dis     Publication Date:    2010 May-Jun
Date Detail:
Created Date:  2010-06-25     Completed Date:  2010-10-12     Revised Date:  2014-11-13    
Medline Journal Info:
Nlm Unique ID:  101256510     Medline TA:  Congenit Heart Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  278-84     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Case-Control Studies
Child
Child, Preschool
Echocardiography, Doppler
Female
Humans
Infant
Male
Mitral Valve / drug effects*,  physiopathology,  ultrasonography
Mitral Valve Insufficiency / drug therapy*,  physiopathology,  ultrasonography
Recovery of Function
Retrospective Studies
Severity of Illness Index
Switzerland
Time Factors
Treatment Outcome
Ventricular Function, Left / drug effects*
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Right ventricular function in congenital heart defects assessed by regional wall motion.
Next Document:  Disparities exist in the emergency department evaluation of pediatric chest pain.